Boltz on open access: powerful models shouldn't be locked in one company's pipeline

GabriCorso · x · 2026-11-18

Boltz argues that models this powerful should be accessible to every scientist, not confined to one company's pipeline or locked behind restrictive strategic partnerships. Its partners now include Pfizer, GSK, Takeda and BMS.

Related event: Boltz Commits to Open Models as Pfizer, GSK, Takeda and BMS Sign On(2 posts)→

Original post →

More from Research

Research channel →